<DOC>
	<DOCNO>NCT01322048</DOCNO>
	<brief_summary>The investigator intend determine effect adrenergic blockade 1 ) short-term physiology , behavior , cognition 2 ) long-term neuropsychological outcome severe Traumatic Brain Injury ( TBI ) . The primary hypothesis adrenergic blockade severe TBI associate increase ventilator-free day .</brief_summary>
	<brief_title>DASH After TBI Study : Decreasing Adrenergic Sympathetic Hyperactivity After Traumatic Brain Injury</brief_title>
	<detailed_description>Severe traumatic brain injury ( TBI ) associate sympathetic hyperactivity result catecholamine excess , abnormal heart rate variability , agitation sympathetic storm , deep white matter change , poor neuropsychological outcome . Notably , persistent sympathetic hyperactivity TBI result higher day mechanical ventilation longer intensive care unit ( ICU ) length stay ( LOS ) . While data describe limited portion response , full spectrum sympathetic hyperactivity severe TBI systemically describe methodically intervene upon . We perform double-blinded , randomize , placebo-controlled pilot trial 100 patient cohort one group receive centrally act sympatholytic drug , propranolol clonidine , group , placebo , within 48 hour severe TBI . The length therapy 7 day . The primary question study whether ventilator-free day increase therapy . Secondary endpoint include plasma urine catecholamine level , heart rate blood pressure variability , responses autonomic cold pressor testing , assessment coma , sedation , agitation , sedative requirement , analgesic use , antipsychotic medication use , coma-free day , ventilator-free day , Intensive Care Unit ( ICU ) length stay , survival . Also , neuropsychological outcome measure ICU discharge , 3 month , 12 month . Interim Analysis : At approximately 50 % target accrual , n=46 randomize subject , interim analysis perform A Priori ( plan ) futility efficacy rule , DSMB IRB approve .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Craniocerebral Trauma</mesh_term>
	<mesh_term>Trauma , Nervous System</mesh_term>
	<mesh_term>Adrenergic Agents</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Age : 16 year 64 year Glasgow Coma Scale score less equal 8 ( Severe TBI ) injury CT Screen within 24 hour injury Preexisting heart disease ( i.e . coronary heart disease ) Preexisting cardiac dysrhythmia Allergy study drug Penetrating brain injury Preexisting brain dysfunction ( i.e . prior severe TBI , debilitate stroke ) Impending brain herniation ( i.e . loss bilateral corneal reflex ) Craniectomy craniotomy Spinal cord injury Myocardial injury Severe liver disease Current use betablockers and/or alpha2agonist Withdrawal care expect 24 hour Prisoners Pregnant woman Unable followup final visit</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Sympathetic Hyperactivity</keyword>
	<keyword>Traumatic Brain Injury</keyword>
	<keyword>Agitation</keyword>
	<keyword>Severe TBI</keyword>
	<keyword>TBI</keyword>
	<keyword>Catecholamines</keyword>
	<keyword>Heart rate variability</keyword>
	<keyword>Adrenergic alpha-Agonists</keyword>
	<keyword>Adrenergic beta-Antagonists</keyword>
	<keyword>Cognitive Impairment</keyword>
</DOC>